Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acurx Pharmaceuticals, LLC*

4.93
+0.21504.56%
Volume:33.00K
Turnover:158.60K
Market Cap:7.81M
PE:-0.36
High:4.98
Open:4.66
Low:4.66
Close:4.72
52wk High:47.60
52wk Low:3.80
Shares:1.58M
Float Shares:1.24M
Volume Ratio:2.04
T/O Rate:2.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.7237
EPS(LYR):-17.4507
ROE:-285.93%
ROA:-98.59%
PB:2.19
PE(LYR):-0.28

Loading ...

Analysts Are Bullish on These Healthcare Stocks: Acurx Pharmaceuticals (ACXP), Biohaven Ltd. (BHVN)

TIPRANKS
·
Aug 15

Acurx Pharmaceuticals Reports Q2 2025 Net Loss of $2.2M, EPS of $1.89; R&D Expenses Drop Significantly

Reuters
·
Aug 12

Acurx Pharmaceuticals Q2 EPS $(1.89) Up from $(5.21) YoY

Benzinga
·
Aug 12

Acurx Pharmaceuticals, Inc. Reports Second Quarter Results and Provides Business Update

THOMSON REUTERS
·
Aug 12

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 11

Acurx Pharmaceuticals Inc. Announces Date for Special Stockholders Meeting

Reuters
·
Aug 05

Acurx Pharmaceuticals trading halted, news pending

TIPRANKS
·
Aug 05

Acurx Pharmaceuticals Announces 1-for-20 Reverse Stock Split Effective August 5, 2025

Reuters
·
Jul 31

Acurx Pharmaceuticals, Inc. Announces Reverse Stock Split

THOMSON REUTERS
·
Jul 31

Acurx Pharmaceuticals Inc - Approves 1-for-20 Reverse Stock Split

THOMSON REUTERS
·
Jul 31

Acurx Pharmaceuticals Inc. Announces Date for Special Stockholders Meeting

Reuters
·
Jul 25

Acurx Pharmaceuticals Inc. Announces Second Quarter 2025 Financial Results Release

Reuters
·
Jul 24

Acurx Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 12, 2025 Conference Call and Provide Business Update

THOMSON REUTERS
·
Jul 24

Acurx Pharmaceuticals Inc. Conducted Annual Meeting of Stockholders

Reuters
·
Jul 18

Acurx files $50M mixed securities shelf

TIPRANKS
·
Jul 10

Acurx Pharmaceuticals Announces $2.67 Million Private Placement Through Warrant Exercise

Reuters
·
Jun 18

Top Midday Gainers

MT Newswires Live
·
Jun 18

Why Is Acurx Pharmaceuticals Stock (ACXP) Up 250% Today?

TIPRANKS
·
Jun 17

Acurx Pharmaceuticals Announces Promising Phase 2b Clinical Trial Results for Ibezapolstat in Treating C. difficile Infection, Prepares for Phase 3 Trials

Reuters
·
Jun 17

BRIEF-Acurx Pharmaceuticals Announces Presentation Of Results From Leiden University Medical Center Public-Private Partnership For Its DNA pol IIIC Inhibitors

Reuters
·
Jun 09